Days after JCR Pharmaceuticals signed a deal with AstraZeneca’s rare disease unit, the Japanese biopharma has secured a ...

The developments are directed towards providing improved treatment options for individuals with Alzheimer’s disease.

The 12-month high-impact executive education programme empowers mid- to senior-level professionals with advanced strategic, ...

CEO Brian Niccol asks Starbucks workers to come back to the office—or he’ll pay them to leave Tropical rainstorm expected to ...

Acumen Pharmaceuticals Inc. and JCR Pharmaceuticals Co. Ltd. have entered a collaboration, option and license agreement to develop a novel therapeutic candidate for the treatment of Alzheimer’s ...

Organizations worldwide are racing to build AI skills across their teams, and Udemy's dynamic instructors and AI-powered ...

By Burt Levine Click here for updates on this story July 15, 2025 (Houston Style Magazine) -- Houston’s political landscape is ...

Acumen and JCR aim to develop a product leveraging Acumen's amyloid beta oligomer-selective antibody expertise and JCR's transferrin-receptor-targeting blood-brain barrier-penetrating technologyPrecli ...

AI proficiency is becoming a differentiator in both hiring and retention,” Major, Lindsey & Africa said in its second-quarter ...

During an emergency, the answer to “Who you gonna call?” typically is the Ghostbusters, but at Skokie, IL-based Legacy Healthcare, the answer often is Pat Winkelman.

High-level meeting on AI governance to be held in tandem with the three-day World Artificial Intelligence Conference, ...

Global nonprofit impact investor Acumen has launched a Valentine’s Day campaign urging chocolate lovers to “Make a #Cocoamitment” by choosing chocolate brands that support fair wages for cocoa farmers ...